Product news from the 07/25/06 News Brief

July 25 2006

The FDA has approved AstraZeneca’s Symbicort (budesonide/formoterol) for the maintenance treatment of asthma in patients age 12 and older. ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.